LORI AKERS: Open Payments
NPI 1417224643 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,656 in 138 payments from 22 companies in 2025. Trend: 2023 $965 · 2024 $1,522 · 2025 $2,656
Food & beverage: $2,656
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 33 | $453 |
| GENZYME CORPORATION | 15 | $391 |
| AstraZeneca Pharmaceuticals LP | 13 | $298 |
| Grifols USA, LLC | 12 | $249 |
| Regeneron Healthcare Solutions, Inc. | 8 | $171 |
| Amgen Inc. | 8 | $169 |
| Insmed, Inc. | 7 | $168 |
| Verona Pharma, Inc. | 8 | $136 |
| Viatris Specialty LLC | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $84 |
Products named: DUPIXENT, TEZSPIRE, Prolastin-C Liquid, NUCALA, TRELEGY ELLIPTA, Arikayce, Ohtuvayre, YUPELRI.
Industry payments across KY — which companies pay providers there.
